Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Akira Endo's Contributions

August 17, 2009 | A version of this story appeared in Volume 87, Issue 33

The book review of "Triumph of the Heart" by John Lamattina, and particularly the role of Akira Endo in finding an HMGCoA reductase inhibitor, reminds me of the story that went around some 20 to 25 years ago (C&EN, June 8, page 61).

The only difference between compactin, Endo's original isolate from fermentations, and lovastatin, the first statin approved for clinical use from Merck, is one methyl group—and a patent. And so an industry was born.

Kenneth E. Neet
North Chicago, Ill.

Article:

This article has been sent to the following recipient:

1 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.